ChemoStart is a global program of Insud Pharma that helps boost startups and companies with innovative projects in health and healthcare.
Following the presentation of 71 high quality projects, Newmanbrain, with the proposal of its THEIA™ functional Near Infrared Spectroscopy (fNIRs) device, has been pre-selected within the VII Edition of the ChemoStart Program.
Chemostart is an initiative developed by Grupo Insud Farma and led by Leandro Sigman to support innovative projects in biotechnology and human health.
The program is open to any type of project in this sector, including the development of new drugs, artificial intelligence, diagnostics, wearables or other types of technology applicable to human health.
It is a fully philanthropic initiative to help entrepreneurs and innovators in this sector.
The selected projects will receive personalized support tailored to their needs, making available our internal resources and an extensive network of collaborators and mentors, specialists in different fields.
The projects will also receive support in obtaining financing and our Group may invest if the project is aligned with our strategic interests.
Newmanbrain Team in Chemostart
Pablo Belmonte (Newmanbrain CEO), Sergio Molina (Newmanbrain Scientific Manager) and Irene Tortosa (Newmanbrain Project Manager) attended the event on behalf of Newmanbrain company.
More Info: InsudPharma Chemostart